| Period Ending | Jun 30, 2013 | Mar 31, 2013 | Dec 31, 2012 | Sep 30, 2012 |
|---|
|
Total Revenue
|
26,003,000
|
26,634,000
|
22,307,000
|
24,466,000
| | Cost of Revenue | 793,000 | 854,000 | 858,000 | 902,000 | | |
Gross Profit
|
-
|
-
|
-
|
-
| |
|
Operating Expenses |
|
Research Development |
-
|
-
|
-
|
-
|
|
Selling General and Administrative | 15,744,000 | 19,224,000 | 18,051,000 | 17,229,000 |
|
Non Recurring |
-
|
-
|
-
|
-
|
|
Others | 1,485,000 | 1,989,000 | 2,513,000 | 2,089,000 |
|
|
|
Total Operating Expenses |
-
|
-
|
-
|
-
| | | |
Operating Income or Loss
|
-
|
-
|
-
|
-
| |
|
Income from Continuing Operations |
|
Total Other Income/Expenses Net |
-
|
-
|
-
|
-
|
|
Earnings Before Interest And Taxes | 8,408,000 | 5,039,000 | 1,305,000 | 4,664,000 |
|
Interest Expense | 2,483,000 | 2,583,000 | 2,789,000 | 3,136,000 |
|
Income Before Tax | 5,498,000 | 1,984,000 | (1,904,000) | 1,110,000 |
|
Income Tax Expense | 1,486,000 | 501,000 | (2,636,000) | 770,000 |
|
Minority Interest |
-
|
-
|
-
|
-
|
|
|
|
Net Income From Continuing Ops | 4,692,000 | 2,046,000 | 1,431,000 | 578,000 | |
|
Non-recurring Events |
|
Discontinued Operations |
-
|
-
|
-
|
-
|
|
Extraordinary Items |
-
|
-
|
-
|
-
|
|
Effect Of Accounting Changes |
-
|
-
|
-
|
-
|
|
Other Items |
-
|
-
|
-
|
-
| | | |
Net Income
|
4,012,000
|
1,483,000
|
732,000
|
340,000
| | Preferred Stock And Other Adjustments | (441,000) | (373,000) | (365,000) | (373,000) | | |
Net Income Applicable To Common Shares
|
3,571,000
|
1,110,000
|
367,000
|
(33,000)
|
|
0.13 (0.94%) 7:19AM EDT - Nasdaq Real Time Price